On the other hand, lncRNA MEG3 attenuates the osteogenic differentiation of bone marrow mesenchymal stem cells from postmenopausal osteoporosis by targeting miR-30b-5p [35]. Here, MEG3 is linked to postmenopausal osteoporosis.